Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for PAVmed Inc. (PAVM : NSDQ)

• Company Description    PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City. Number of Employees: 89

• Price / Volume Information    Yesterday's Closing Price: $1.03 Daily Weekly Monthly 20 Day Moving Average: 2,419,489 shares Shares Outstanding: 87.96 (millions) Market Capitalization: $90.60 (millions) Beta: 0.22 52 Week High: $9.70 52 Week Low: $0.94 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.83% 6.07% 12 Week -30.41% -24.78% Year To Date -58.13% -50.41%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL ONE GRAND CENTRAL PLACE 60 E. 42ND STREET SUITE 4600 - NEW YORK,NY 10165 USA ph: 212-949-4319 fax: - pavmed@lavoiehealthscience.com http://www.pavmed.com

• General Corporate Information    Officers Lishan Aklog - Chief Executive Officer and Chairman of the Board Michael J. Glennon - Vice Chairman Dennis M. McGrath - President and Chief Financial Officer Debra J. White - Director James L. Cox - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 70387R106 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 87.96 Most Recent Split Date: (:1) Beta: 0.22 Market Capitalization: $90.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.89 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.18 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -75.00% vs. Previous Quarter: 6.67% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -37.00% ROE 03/31/22 - -86.63 12/31/21 - -76.84 09/30/21 - -108.12 ROA 03/31/22 - -73.00 12/31/21 - -65.47 09/30/21 - -76.90 Current Ratio 03/31/22 - - 12/31/21 - 10.93 09/30/21 - 5.38 Quick Ratio 03/31/22 - - 12/31/21 - 10.93 09/30/21 - 5.38 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - -11,225.20 09/30/21 - -22,853.50 Book Value 03/31/22 - - 12/31/21 - 0.88 09/30/21 - 0.39 Inventory Turnover 03/31/22 - - 12/31/21 - 46.80 09/30/21 - 11.52 Debt-to-Equity 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©